THE COMBINED CT AND PET-CT RESPONSE ACCURATELY PREDICTS PATHOLOGICAL RESPONSE IN PATIENTS TREATED WITH BEVACIZUMAB-BASED NEOADJUVANT CHEMOTHERAPY IN INITIALLY RESECTABLE COLORECTAL LIVER METASTASES

被引：0
|
作者：
Aderka, Dan [1 ]
Golan, Talia [1 ]
Wolf, Ido [1 ]
Shmueli, Einat [2 ]
Figer, Arie [2 ]
Brener, Baruch [5 ]
Beny, Alex [3 ]
Klein, Baruch [4 ]
Catane, Raphael [1 ]
机构：
[1] Chaim Sheba Med Ctr, Div Oncol, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[3] Rambam Med Ctr, Haifa, Israel
[4] Meir Med Ctr, Kefar Sava, Israel
[5] Rabin Med Ctr, Petah Tiqwa, Israel
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v23 / v23
页数：1
相关论文
共 50 条
  • [21] GAME-SCORE predicts pathological and radiological response to chemotherapy in patients with colorectal liver metastases
    Russolillo, Nadia
    Zingaretti, Caterina C.
    Langella, Serena
    Fontana, Andrea P.
    Lo Tesoriere, Roberto
    Ferrero, Alessandro
    EJSO, 2024, 50 (11):
  • [22] Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel
    Garcia Garcia-Esquinas, Marta A.
    Arrazola Garcia, Juan
    Garcia-Saenz, Jose A.
    Furio-Bacete, V.
    Fuentes Ferrer, Manuel E.
    Ortega Candil, Aida
    Cabrera Martin, Maria N.
    Carreras Delgado, Jose L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (01): : 14 - 21
  • [23] Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases
    Stift, Judith
    Graf, Alexandra
    Schwarz, Christoph
    Tamandl, Dietmar
    Starlinger, Patrick
    Herac, Merima
    Beer, Andrea
    Wrba, Friedrich
    Bodingbauer, Martin
    Kaczirek, Klaus
    Stremitzer, Stefan
    EJSO, 2018, 44 (01): : 139 - 147
  • [24] Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX
    Markus Klinger
    Dietmar Tamandl
    Sandra Eipeldauer
    Stefan Hacker
    Beata Herberger
    Klaus Kaczirek
    Marion Dorfmeister
    Birgit Gruenberger
    Thomas Gruenberger
    Annals of Surgical Oncology, 2010, 17 : 2059 - 2065
  • [25] Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX
    Klinger, Markus
    Tamandl, Dietmar
    Eipeldauer, Sandra
    Hacker, Stefan
    Herberger, Beata
    Kaczirek, Klaus
    Dorfmeister, Marion
    Gruenberger, Birgit
    Gruenberger, Thomas
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2059 - 2065
  • [26] Complete pathological response of colorectal liver metastases after neoadjuvant chemotherapy: myth or reality?
    Wicherts, D. A.
    Haas de, R. J.
    Levi, F.
    Aloia, T.
    Paule, B.
    Bralet, M.
    Kunstlinger, F.
    Azoulay, D.
    Castaing, D.
    Adam, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases
    Daza, Julian E.
    Solis, Natalie M.
    Parpia, Sameer
    Gallinger, Steven
    Moulton, Carol-Anne
    Belley-Cote, Emilie P.
    Levine, Mark N.
    Serrano, Pablo E.
    EJSO, 2019, 45 (08): : 1341 - 1348
  • [28] CT and FDG PET/CT evaluation of response to NV1020 for liver colorectal metastases
    Iagaru, Andrei
    Sze, Daniel
    Gambhir, Sanjiv
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [29] OUTCOMES OF MIXED PATHOLOGIC RESPONSE IN PATIENTS WITH MULTIPLE COLORECTAL LIVER METASTASES TREATED WITH NEOADJUVANT CHEMOTHERAPY AND LIVER RESECTION
    Mason, Meredith C.
    Krasnodebski, Maciej
    Barker, Caeli
    Nishioka, Yujiro
    Kothari, Anai N.
    Chiang, Yi-Ju
    Newhook, Timothy E.
    Tzeng, Ching-Wei D.
    Chun, Yun Shin
    Aloia, Thomas
    Vauthey, Jean-Nicolas
    Cao, Hop Tran
    GASTROENTEROLOGY, 2021, 160 (06) : S899 - S900
  • [30] 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy
    Funaioli, Chiara
    Pinto, Carmine
    Di Fabio, Francesca
    Santini, Donatella
    Ceccarelli, Claudio
    De Raffaele, Emilio
    Fanti, Stefano
    Castellucci, Paolo
    Longobardi, Ciro
    Buggi, Federico
    Martoni, Andrea Angelo
    TUMORI JOURNAL, 2007, 93 (06): : 611 - 615
12345